Hsing‐Hui Wang
Impact in
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
Papers in
- Co-authors
- Eva Y.-H.P. Lee (1 shared paper)Wen‐Hwa Lee (1 shared paper)John T. Kung (1 shared paper)Wendy W. Hwang‐Verslues (1 shared paper)King‐Jen Chang (1 shared paper)Wen‐Hung Kuo (1 shared paper)Chung‐Hsuan Chen (1 shared paper)Yung‐Ming Jeng (1 shared paper)
- Journals
- The Prostate (2 papers)Nature Communications (1 paper)Clinical Cancer Research (1 paper)JCI Insight (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesNetherlandsTaiwan
In The Last Decade
Hsing‐Hui Wang
6 papers receiving 304 citations
Peers
Comparison fields: 5 of 51
- Oncology 163
- Otorhinolaryngology 18
- Cancer Research 56
- Urology 20
- Immunology 58
Countries citing papers authored by Hsing‐Hui Wang
This map shows the geographic impact of Hsing‐Hui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsing‐Hui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsing‐Hui Wang more than expected).
Fields of papers citing papers by Hsing‐Hui Wang
This network shows the impact of papers produced by Hsing‐Hui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsing‐Hui Wang. The network helps show where Hsing‐Hui Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hsing‐Hui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 172 | |
| 2 | 2011 | 40 | |
| 3 | 2017 | 38 | |
| 4 | 2020 | 30 | |
| 5 | 2024 | 15 | |
| 6 | 2015 | 13 |
About Hsing‐Hui Wang
Hsing‐Hui Wang is a scholar working on Oncology, Surgery, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Immunology, having authored 6 papers that have together received 308 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Urinary and Genital Oncology Studies (1 paper), Head and Neck Cancer Studies (1 paper), Immunotherapy and Immune Responses (1 paper), Cancer Cells and Metastasis (1 paper), Cancer Genomics and Diagnostics (1 paper), Immune Cell Function and Interaction (1 paper) and Neonatal Respiratory Health Research (1 paper). The work is most often cited by research in Oncology (163 citations), Otorhinolaryngology (18 citations), Cancer Research (56 citations), Urology (20 citations) and Immunology (58 citations). Hsing‐Hui Wang has collaborated with scholars based in United States, Netherlands and Taiwan. Frequent co-authors include Eva Y.-H.P. Lee, Wen‐Hwa Lee, John T. Kung, Wendy W. Hwang‐Verslues, King‐Jen Chang, Wen‐Hung Kuo, Chung‐Hsuan Chen, Yung‐Ming Jeng, Scott A. Crist and Timothy L. Ratliff. Their work appears in journals such as The Prostate, Nature Communications, Clinical Cancer Research, JCI Insight and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.